On Nov. 12, the FDA will focus on developing analytical standards for NGS, and on Nov. 13 the topic will be variant databases for clinical interpretation.
As the number of people genotyped looks set to pass 3 million this year, third-party tools providers have worked to improve usability, add features, and upgrade their servers for scalability.
The firm will provide whole-genome profiling for Cedars-Sinai prostate cancer patients, who will also be tested with the Decipher Prostate Cancer Classifier.
Under the terms of the agreement, Repositive will offer access to a range of biomedical science research datasets from GigaScience.
The availability of consumer genomics services has also made it possible for adoptees to bypass state adoption laws, many of which restrict access to their records.
The database currently includes 60 oncogenes with variants associated with therapies and clinical trials, or that have been functionally characterized.
The graph-based tools will allow researchers to query large datasets and identify defining patterns of variation across cancer types and subtypes.
Twelve hospitals will use the company's assays to screen vulnerable patients for genes from multi-drug resistant organisms.
The company is developing a search application that will allow users to explore genomic datasets without accessing sensitive information.
CiViC provides a communal forum for capturing and sharing written summaries, drawn from published literature, about the clinical relevance of mutations found in cancer.
An analysis by the Personal Medicine Coalition finds that about a quarter of new drugs approved in 2019 by the US Food and Drug Administration were personalized medicines.
The governor of New York has proposed a five-year plan to study the genomes of people with or who are at high risk of developing Alzheimer's disease.
The New York City Police Department will be removing DNA profiles from a local database if they are from people who were never convicted of a crime, the New York Times reports.
Science reports that accusations of sexual assault against a microbiome researcher has also led to questions about his academic certifications.